Recipharm has a total of 629 patents globally, out of which 429 have been granted. Of these 629 patents, more than 42% patents are active. United Kingdom is where Recipharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, United Kingdom seems to be the main focused R&D centre and Sweden is the origin country of Recipharm.
Recipharm founded in 1995, Recipharm is a global contract development and manufacturing organization (CDMO) supporting pharmaceutical companies across the product lifecycle. Its services span drug development, formulation, analytical testing, biologics, drug substance and drug product manufacturing, and commercial production. With operations across Europe, India, and the US, Recipharm combines global capabilities with localized expertise to deliver end-to-end pharmaceutical solutions.
Do read about some of the most popular patents of Recipharm which have been covered by us in this article and also you can find Recipharm patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Recipharm patent portfolio.
How many patents does Recipharm have?
Recipharm has a total of 629 patents globally. These patents belong to 129 unique patent families. Out of 629 patents, 273 patents are active.
How Many Patents did Recipharm File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Recipharm Applications Filed | Recipharm Patents Granted |
| 2026 | 2 | 1 |
| 2025 | 9 | – |
| 2024 | 1 | 4 |
| 2023 | – | 8 |
| 2022 | 6 | 17 |
| 2021 | 1 | 16 |
| 2020 | 2 | 37 |
| 2019 | 3 | 46 |
| 2018 | 9 | 51 |
| 2017 | 7 | 57 |
How many Recipharm patents are Alive/Dead?
Worldwide Patents
How Many Patents did Recipharm File in Different Countries?
Countries in which Recipharm Filed Patents
| Country | Patents |
| United Kingdom | 108 |
| Europe (EPO) | 82 |
| United States of America | 60 |
| Germany | 41 |
| Austria | 35 |
| India | 28 |
| Canada | 27 |
| China | 24 |
| Australia | 22 |
| Italy | 20 |
| Spain | 18 |
| Japan | 16 |
| Brazil | 14 |
| Poland | 8 |
| Denmark | 6 |
| Portugal | 6 |
| Slovakia | 5 |
| Estonia | 5 |
| Slovenia | 5 |
| Cyprus | 5 |
| Hungary | 4 |
| Korea (South) | 4 |
| Lithuania | 4 |
| Turkey | 3 |
| Norway | 3 |
| France | 2 |
| South Africa | 2 |
| Israel | 1 |
| New Zealand | 1 |
| Russia | 1 |
| Hong Kong (S.A.R.) | 1 |
| Cuba | 1 |
| Egypt | 1 |
| Georgia | 1 |
| Costa Rica | 1 |
| Chile | 1 |
| Mexico | 1 |
| Peru | 1 |
| Nicaragua | 1 |
| Dominican Republic | 1 |
| Argentina | 1 |
Where are Research Centres of Recipharm Patents Located?
10 Best Recipharm Patents
WO2007083115A1 is the most popular patent in the Recipharm portfolio. It has received 234 citations so far from companies like Ucb Pharma Sa, Shl Group Ab and Kaleo Inc.
Below is the list of 10 most cited patents of Recipharm:
| Publication Number | Citation Count |
| WO2007083115A1 | 234 |
| US20070173770A1 | 134 |
| WO2011012903A1 | 117 |
| US20120016296A1 | 105 |
| US20120130342A1 | 87 |
| WO2008075033A1 | 67 |
| US7195134B2 | 66 |
| GB2447339A | 63 |
| GB2447787A | 58 |
| US7191918B2 | 56 |
What are Recipharm key innovation segments?
What Technologies are Covered by Recipharm?
The chart below distributes patents filed by Recipharm